Lactobacillus treatment for catheter-related urinary symptoms
Part of Brain & nervous system, Kidney & urinary, Women’s health & pregnancy clinical trials.
This trial tests whether placing a probiotic called Lactobacillus directly into the bladder can reduce urinary symptoms and bladder infections in people who have bladder problems from nerve damage and use an indwelling catheter. It may help by changing the bacteria living in the bladder.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have neurogenic bladder (bladder symptoms from nerve problems) for at least 6 months
- You use an indwelling catheter most/all of the time for bladder emptying
- You live in the community (not in a hospital or nursing facility as your main setting)
- You are physically disabled and need assistance for daily activities
- You are willing and able to follow study instructions and schedule visits
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study asks patients and caregivers about their experiences with bladder washes (instillations) using lactobacillus or gentamicin to manage urinary symptoms. Your feedback could help improve care for others like you.
This trial tests if putting a live bacteria called Lactobacillus crispatus into the bladder is safe for people with spinal cord injury and neurogenic lower urinary tract dysfunction. It may help prevent urinary tract infections without antibiotics.
This study tests whether putting a probiotic called LGG into the bladder works better than a saline bladder rinse to help people with a nerve-related bladder problem. It may improve bladder symptoms or reduce bladder infections, compared with standard saline rinses.
This study tests whether washing the bladder with a solution called chlorhexidine (a germ-killer) can lower the number of unplanned hospital visits and improve quality of life for people who have a long-term suprapubic catheter. You may be eligible if you have had a catheter for at least a year and have had a recent urinary tract infection.
This trial tests whether a medication called OM-89 (a bacterial extract taken by mouth) can help reduce how often you need antibiotics for urinary tract infections (UTIs). It is for people with a neurogenic bladder from a spinal cord injury who use a catheter to empty their bladder and have had many UTIs in the past year.
This early-stage trial tests a new treatment combining an antibiotic (gentamicin) and beneficial bacteria (lactobacillus) instilled directly into the bladder to help prevent urinary tract infections in people with neurogenic bladder—a condition where nerve damage affects bladder control. The goal is to see if this approach is safe and helps reduce infection risk.
Hear when a new Neurogenic Bladder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.